An individual suffering from post-traumatic stress disorder (PTSD) can continue to re-experience the traumatic incident, which can involve a sense of extreme fear. In this article, the authors describe the case of a 36-year-old gentleman in whom the use of propranolol for the management of these persistent PTSD symptoms proved beneficial and led to the resolution of his flashback symptoms following difficulty in initial management with multiple other first-line treatment modalities. Propranolol is currently not licensed for use in PTSD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.